Eric Chow, MD

Assistant Member
Clinical Research Division
University of Washington
Medical Director, Cancer Survivorship Program, LIVESTRONG Survivorship Center of Excellence
Seattle Children's Hospital


M.D. with thesis, University of California, San Francisco, 2001.
M.P.H., University of California, Berkeley, Epidemiology and Biostatistics, 2000.
B.S., Yale University, Biology with distinction, magna cum laude, 1996.

Research Focus:

Late effects related to pediatric cancer and blood disorder therapy.

Clinical Expertise:

Late effects related to pediatric cancer and blood disorder therapy.

Current Studies:

  • K07 CA151775-01A1 (PI: Chow, E) 8/1/2011-7/30/2016. Determinants of late cardiovascular morbidity among survivors of hematopoietic cell transplantation.
  • FND (PI: Chow, E) 10/1/2008-12/31/2012. Hyundai Hope on Wheels Cancer Research Scholarship. Glucocorticoids and insulin resistance among children undergoing treatment for acute lymphoblastic leukemia.
  • U24CA 55727 (PI: Robison, L) 12/1/2011-11/30/2016. Childhood Cancer Survivor Study is an NCI-funded resource study whose primary goal is to study the late effects among a cohort of childhood cancer survivors. Role: co-investigator, Executive Committee member.
  • R01 CA112530 (PI: Baker, KS) 8/15/2006–7/31/2012. Metabolic syndrome following transplant for leukemia. Evaluate the relationship between HCT specific treatment exposures and the development of insulin resistance and the MS in adolescent and young adult survivors after HCT for treatment of hematologic malignancies in childhood Role: co-investigator.

Eric Chow, MD, MPH

Contact Information

(206) 667-7724
(206) 667-5948
Additional contact

Mail Stop: M4-C308